VISANI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 3.936
AS - Asia 3.713
EU - Europa 2.549
Continente sconosciuto - Info sul continente non disponibili 213
SA - Sud America 200
AF - Africa 192
OC - Oceania 7
Totale 10.810
Nazione #
US - Stati Uniti d'America 3.841
VN - Vietnam 1.668
GB - Regno Unito 789
SG - Singapore 742
CN - Cina 640
IT - Italia 522
SE - Svezia 306
DE - Germania 244
HK - Hong Kong 210
BR - Brasile 152
FR - Francia 138
RU - Federazione Russa 118
IN - India 108
NL - Olanda 101
IE - Irlanda 84
ZA - Sudafrica 69
CA - Canada 56
CI - Costa d'Avorio 50
FI - Finlandia 50
KR - Corea 47
JP - Giappone 43
UA - Ucraina 41
JO - Giordania 36
BG - Bulgaria 33
CH - Svizzera 31
BD - Bangladesh 30
EE - Estonia 29
ID - Indonesia 28
PH - Filippine 25
TG - Togo 25
SC - Seychelles 21
PK - Pakistan 20
IR - Iran 18
TR - Turchia 18
MX - Messico 17
AR - Argentina 14
IQ - Iraq 14
AT - Austria 13
TH - Thailandia 12
PL - Polonia 10
UZ - Uzbekistan 10
EC - Ecuador 9
GR - Grecia 9
SA - Arabia Saudita 8
CO - Colombia 7
TW - Taiwan 7
MY - Malesia 6
AU - Australia 5
PE - Perù 5
PY - Paraguay 5
BE - Belgio 4
EG - Egitto 4
ES - Italia 4
GT - Guatemala 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
PT - Portogallo 4
SN - Senegal 4
CY - Cipro 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
NG - Nigeria 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KE - Kenya 2
KW - Kuwait 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
TT - Trinidad e Tobago 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GD - Grenada 1
GP - Guadalupe 1
KG - Kirghizistan 1
KI - Kiribati 1
ML - Mali 1
MT - Malta 1
MW - Malawi 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 10.592
Città #
Southend 733
Singapore 508
Ashburn 448
Ho Chi Minh City 437
Hanoi 369
Fairfield 354
Chandler 213
Hong Kong 202
Houston 165
Seattle 158
Woodbridge 152
San Jose 146
Cambridge 141
Wilmington 138
Santa Clara 127
Bologna 126
Hefei 112
Dong Ket 97
Princeton 94
Ann Arbor 85
Dallas 83
Dublin 82
Los Angeles 81
Beijing 80
New York 76
Council Bluffs 66
Boardman 62
Da Nang 58
Lauterbourg 51
Abidjan 50
Turin 45
Helsinki 44
Seoul 43
Redmond 42
Haiphong 40
Nanjing 37
Padova 37
Amman 36
Westminster 36
Johannesburg 35
Tokyo 35
Berlin 34
Sofia 33
Milan 29
Quận Bình Thạnh 28
Saint Petersburg 28
Bern 27
Ha Long 27
Phoenix 26
Vũng Tàu 26
Lomé 25
San Diego 25
Thái Nguyên 25
Hải Dương 24
Ninh Bình 24
Buffalo 22
São Paulo 22
Jacksonville 21
Florence 19
Shenyang 19
Biên Hòa 18
Bắc Giang 18
Jakarta 18
Denver 17
Jinan 17
Montreal 17
Redondo Beach 17
Oldenburg 16
Redwood City 16
Rome 16
Brooklyn 15
Dearborn 15
Nanchang 15
San Francisco 15
Điện Bàn 15
Chicago 14
London 14
Can Tho 13
Changsha 13
Orem 13
Bắc Ninh 12
Quận Một 12
Vinh 12
Atlanta 11
Lang Son 11
Mülheim 11
Shanghai 11
Toronto 11
Bengaluru 10
Des Moines 10
Hangzhou 10
Hebei 10
Tianjin 10
Warsaw 10
Bremen 9
Fremont 9
Guangzhou 9
Jiaxing 9
Kuban 9
Paris 9
Totale 6.925
Nome #
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 642
Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. 601
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 456
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 441
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 350
Molecular biology of biliopancreatic lesions 342
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma 302
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 273
A novel T137A SOD1 mutation in an Italian family with two subjects affected by amyotrophic lateral sclerosis 266
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 263
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option? 249
Next-generation technologies in predictive molecular pathology of lung cancers 247
T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer 234
Activity of the novel T137A SOD1 mutation in amyotrophic lateral sclerosis patients 232
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 228
Evaluation of RNA from human trabecular bone and identification of stable reference genes 221
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 218
RET mutation and increased angiogenesis in medullary thyroid carcinomas 216
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 201
Relevance of ARID1A Mutations in Endometrial Carcinomas 201
Brachial amyotrophic diplegia associated with the a140a superoxide dismutase 1 mutation. 198
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomas 194
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma? 194
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 192
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 187
Prevalence of Antigens/Antibodies Against Hepatitis B and C Viruses in A Cohort of Italian Patients with Pancreatic Adenocarcinoma Admitted to Two Hospital Wards in Italy: A Pivotal Retrospective Study 185
Team work and cytopathology molecular diagnosis of solid pancreatic lesions 180
MiR-196B-5P and miR-200B-3P are differentially expressed in medulloblastomas of adults and children 180
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 177
Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions 173
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 171
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas 171
Search for HBV and HCV Genome in Cancer Cells of Pancreatic Tumors 163
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma 158
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma 152
Contribution of microRNA analysis to characterisation of pancreatic lesions: A review 151
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses 150
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy) 146
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 144
Multiple KRAS Mutations in Pancreatic Adenocarcinoma: Molecular Features of Neoplastic Clones Indicate the Selection of Divergent Populations of Tumor Cells. 143
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas. 142
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 142
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses 132
Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. 123
BRAF V600E and risk stratification of thyroid microcarcinoma: A multicenter pathological and clinical study 123
Molecular diagnosis of carcinomas of the thyroid gland. 121
Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia. 119
null 110
Erratum to Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells (Pituitary, (2015),10.1007/s11102-015-0669-y) 84
null 65
Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells 57
Totale 10.810
Categoria #
all - tutte 28.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022854 0 0 62 74 79 57 19 45 47 61 272 138
2022/20231.063 98 143 64 112 63 87 31 69 182 43 97 74
2023/2024315 40 51 18 39 34 50 19 10 13 20 9 12
2024/20251.242 63 164 107 97 161 68 83 30 12 104 82 271
2025/20264.191 1.169 308 259 233 292 152 331 100 562 188 516 81
2026/2027203 68 101 34 0 0 0 0 0 0 0 0 0
Totale 10.810